Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01578499 |
|---|---|
| Brief Title: | A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) (ALCANZA) |
| First Submitted : | March 27, 2012 |
| First Submitted that Met QC Criteria : | April 13, 2012 |
| First Posted : | April 17, 2012 (Estimate) |
| Results First Submitted : | December 9, 2017 |
| Results First Submitted that Met QC Criteria : | February 19, 2018 |
| Results First Posted : | March 16, 2018 |
| Certification/Extension First Submitted : | February 2, 2017 |
| Certification/Extension First Submitted that Met QC Criteria : | February 2, 2017 |
| Certification/Extension First Posted : | February 3, 2017 (Estimate) |
| Last Update Submitted that Met QC Criteria : | December 16, 2020 |
| Last Update Posted : | January 5, 2021 |